Posted by Michael Wonder on 08 Nov 2023
Zydus receives US FDA approval for Zituvimet to treat adult patients with type 2 diabetes mellitus
6 November 2023 - The company received final approval from the US FDA for its new drug application for Zituvimet (sitagliptin and metformin hydrochloride) 50 mg/500 mg and 50 mg/1000 mg tablets.
Zydus Lifesciences today announced that the US FDA approved its new drug application for Zituvimet (Sitagliptin and Metformin hydrochloride) 50 mg/500 mg and 50 mg/1000 mg tablets.
